Ferric Diphosphate for Oral Iron in Children: Advantages and Disadvantages
Critical Assessment
Ferric diphosphate is not mentioned in any current pediatric iron deficiency anemia guidelines or comparative studies, and therefore cannot be recommended for treating iron deficiency anemia in children aged 6 months to 12 years. The established standard of care remains ferrous sulfate at 3 mg/kg/day administered between meals 1, 2.
Standard Treatment: Ferrous Sulfate
The Centers for Disease Control and Prevention establishes ferrous sulfate as the preferred oral iron formulation because it is the most cost-effective and provides known amounts of elemental iron 2. The recommended dosing is:
- 3 mg/kg/day of elemental iron administered between meals for children with uncomplicated iron deficiency anemia 1, 2, 3
- Treatment should continue for 2-3 months after hemoglobin normalization to replenish iron stores 2, 3
- Response monitoring at 4 weeks: hemoglobin increase ≥1 g/dL or hematocrit ≥3% confirms adequate response 1, 2, 3
Available Oral Iron Formulations: Evidence-Based Comparison
Ferrous Salts (Standard)
Advantages:
- Proven efficacy with highest median hemoglobin increase at 2 and 8 weeks compared to alternative formulations 4
- Decades of safety data in pediatric populations 5, 6
- Low cost and wide availability 2, 6
- Normalization of hemoglobin in 95% and ferritin in 84% of children at 3 months 5
Disadvantages:
- Gastrointestinal side effects in 14-16% of patients (nausea, vomiting, dyspepsia, constipation) 4, 1
- Must be given between meals for optimal absorption, which can reduce compliance 2
- Food interactions can reduce absorption by up to 50% 2
Ferric Iron Salts
Advantages:
- Lower gastrointestinal side effects (6% reported) compared to ferrous salts 4
Disadvantages:
- Less effective than ferrous preparations with lower hemoglobin increases 4
- Limited pediatric data compared to ferrous sulfate 6
- The literature review confirms that ferrous sulfate preparations remain the established standard given their superior bioavailability and efficacy 6
Alternative Formulations (Bis-glycinate, Liposomal)
- Bis-glycinate iron (0.45 mg/kg) showed good efficacy/safety profile with only 6% gastrointestinal side effects 4
- Liposomal iron (0.7-1.4 mg/kg) reported 0% gastrointestinal side effects 4
- However, these formulations showed lower hemoglobin increases compared to ferrous salts 4
When Oral Iron Fails
If anemia persists after 4 weeks of compliant oral iron therapy, obtain MCV, RDW, and repeat serum ferritin 1, 7. Consider:
- Intravenous iron therapy for children unresponsive to oral iron 8, 9
- Ferric carboxymaltose achieved target ferritin ≥30 µg/L in 85% of pediatric patients after single dose 8
- Complete or partial hematological response in 83% of children with iron deficiency anemia 8
- Clinical improvement in 85% of patients with excellent safety profile 8
Critical Pitfalls to Avoid
- Do not use iron polysaccharide complex: Despite higher cost, it is no better tolerated and may be less effective than ferrous sulfate 2
- Do not add ascorbic acid: It does not improve ferrous iron absorption 2
- Avoid aluminum-based phosphate binders: These reduce iron absorption 2
- Do not administer iron within 2 hours before or 1 hour after meals to maximize absorption 2
- Excessive milk intake (>24 oz/day) can displace iron-rich foods and contribute to ongoing deficiency 1, 7
Monitoring and Follow-Up
- Reticulocyte counts increase significantly after 3 days from starting oral iron supplementation 4
- Hemoglobin increase appears at 2 weeks of treatment 4
- Reassess hemoglobin approximately 6 months after successful treatment completion 1
Bottom Line on Ferric Diphosphate
There is no published evidence supporting the use of ferric diphosphate in pediatric iron deficiency anemia. Without guideline recommendations, comparative efficacy data, or safety studies in children, this formulation cannot be recommended over the well-established ferrous sulfate standard 1, 2, 3, 6.